Ignore the ‘superpower’ boasts – UK pharma looks superchallenged | Nils Pratley
Big pharma is unhappy about the prices it is being paid in the UK – a state of affairs the rest of us might instinctively regard as welcome, as it suggests the NHS is still world class when it comes to negotiating terms for branded medicines. The UK spends about 9% of its healthcare budget … Read more